Rituximab Therapy for Thrombotic Thrombocytopenic Purpura: A Proposed Study of the Transfusion Medicine/Hemostasis Clinical Trials Network With a Systematic Review of Rituximab Therapy for Immune-Mediated Disorders

Journal of Clinical Apheresis - United States
doi 10.1002/jca.20091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Combination Therapy of Rituximab and Corticosteroids for Patients With Refractory Chronic Immune Thrombocytopenic Purpura: Report on Two Cases

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2013English

Comparison of the Long-Term Remission of Rituximab and Conventional Treatment for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2019English

Rituximab for Children With Immune Thrombocytopenia: A Systematic Review

PLoS ONE
Multidisciplinary
2012English

Rituximab-Induced Acute and Delayed Serum Sickness in Thrombotic Thrombocytopenic Purpura: The Role of Anti-Rituximab Antibodies

British Journal of Haematology
Hematology
2018English

Relapsing or Refractory Idiopathic Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: The Role of Rituximab

Transfusion
AllergyImmunologyHematology
2010English

Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated With or Without Rituximab

Thrombosis and Haemostasis
Hematology
2018English

Therapeutic Effects of Rituximab Combined With Cyclophosphamide on Refractory Idiopathic Thrombocytopenic Purpura

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Thrombotic Thrombocytopenic Purpura

American Journal of Medicine
Medicine
1959English

Rituximab Therapy for Childhood Evans Syndrome

Haematologica
Hematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy